Reports - VNA and PACS Market
Biotechnology and Life SciencesVNA and PACS Market
VNA and PACS Market Size, Growth Projections And Insights 2025-2035 by Imaging Modality (Angiography, Mammography, Computed Tomography, Magnetic Resonance Imaging), by Type (PACS Vender, VNA Software), by Mode of Delivery (On-Site (Premise), Hybrid, Web/Cloud-based), by Usage Model (Single Department, Multiple Departments, Multiple Sites), by Regions (North America, Europe, Asia Pacific, Latin America
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global VNA and PACS Market - Segment Analysis
1. Overview
2. Global VNA and PACS Market, 2021 - 2035 (USD Million)
3. Global VNA and PACS Market - by Imaging Modality
3.1. By Angiography
3.2. By Mammography
3.3. By Computed Tomography
3.4. By Magnetic Resonance Imaging
3.5. By Ultrasound
3.6. By Other Imaging Modalities
4. Global VNA and PACS Market - by Type
4.1. By PACS Vender
4.2. By VNA Software
5. Global VNA and PACS Market - by Mode of Delivery
5.1. By On-Site (Premise)
5.2. By Hybrid
5.3. By Web/Cloud-based
6. Global VNA and PACS Market - by Usage Model
6.1. By Single Department
6.2. By Multiple Departments
6.3. By Multiple Sites
7. Global VNA and PACS Market - by region
7.1. North America
7.2. Europe
7.3. Asia Pacific
7.4. Latin America
7.5. Middle East & Africa
8. Market comparative analysis
Chapter 4 North America VNA and PACS Market - Segment Analysis
1. Overview
2. North America VNA and PACS Market, 2021 - 2035 (USD Million)
3. North America VNA and PACS Market - by Imaging Modality
3.1. By Angiography
3.2. By Mammography
3.3. By Computed Tomography
3.4. By Magnetic Resonance Imaging
3.5. By Ultrasound
3.6. By Other Imaging Modalities
4. North America VNA and PACS Market - by Type
4.1. By PACS Vender
4.2. By VNA Software
5. North America VNA and PACS Market - by Mode of Delivery
5.1. By On-Site (Premise)
5.2. By Hybrid
5.3. By Web/Cloud-based
6. North America VNA and PACS Market - by Usage Model
6.1. By Single Department
6.2. By Multiple Departments
6.3. By Multiple Sites
Chapter 5 Europe VNA and PACS Market - Segment Analysis
1. Overview
2. Europe VNA and PACS Market, 2021 - 2035 (USD Million)
3. Europe VNA and PACS Market - by Imaging Modality
3.1. By Angiography
3.2. By Mammography
3.3. By Computed Tomography
3.4. By Magnetic Resonance Imaging
3.5. By Ultrasound
3.6. By Other Imaging Modalities
4. Europe VNA and PACS Market - by Type
4.1. By PACS Vender
4.2. By VNA Software
5. Europe VNA and PACS Market - by Mode of Delivery
5.1. By On-Site (Premise)
5.2. By Hybrid
5.3. By Web/Cloud-based
6. Europe VNA and PACS Market - by Usage Model
6.1. By Single Department
6.2. By Multiple Departments
6.3. By Multiple Sites
Chapter 6 Asia Pacific VNA and PACS Market - Segment Analysis
1. Overview
2. Asia Pacific VNA and PACS Market, 2021 - 2035 (USD Million)
3. Asia Pacific VNA and PACS Market - by Imaging Modality
3.1. By Angiography
3.2. By Mammography
3.3. By Computed Tomography
3.4. By Magnetic Resonance Imaging
3.5. By Ultrasound
3.6. By Other Imaging Modalities
4. Asia Pacific VNA and PACS Market - by Type
4.1. By PACS Vender
4.2. By VNA Software
5. Asia Pacific VNA and PACS Market - by Mode of Delivery
5.1. By On-Site (Premise)
5.2. By Hybrid
5.3. By Web/Cloud-based
6. Asia Pacific VNA and PACS Market - by Usage Model
6.1. By Single Department
6.2. By Multiple Departments
6.3. By Multiple Sites
Chapter 7 Latin America VNA and PACS Market - Segment Analysis
1. Overview
2. Latin America VNA and PACS Market, 2021 - 2035 (USD Million)
3. Latin America VNA and PACS Market - by Imaging Modality
3.1. By Angiography
3.2. By Mammography
3.3. By Computed Tomography
3.4. By Magnetic Resonance Imaging
3.5. By Ultrasound
3.6. By Other Imaging Modalities
4. Latin America VNA and PACS Market - by Type
4.1. By PACS Vender
4.2. By VNA Software
5. Latin America VNA and PACS Market - by Mode of Delivery
5.1. By On-Site (Premise)
5.2. By Hybrid
5.3. By Web/Cloud-based
6. Latin America VNA and PACS Market - by Usage Model
6.1. By Single Department
6.2. By Multiple Departments
6.3. By Multiple Sites
Chapter 8 Middle East & Africa VNA and PACS Market - Segment Analysis
1. Overview
2. Middle East & Africa VNA and PACS Market, 2021 - 2035 (USD Million)
3. Middle East & Africa VNA and PACS Market - by Imaging Modality
3.1. By Angiography
3.2. By Mammography
3.3. By Computed Tomography
3.4. By Magnetic Resonance Imaging
3.5. By Ultrasound
3.6. By Other Imaging Modalities
4. Middle East & Africa VNA and PACS Market - by Type
4.1. By PACS Vender
4.2. By VNA Software
5. Middle East & Africa VNA and PACS Market - by Mode of Delivery
5.1. By On-Site (Premise)
5.2. By Hybrid
5.3. By Web/Cloud-based
6. Middle East & Africa VNA and PACS Market - by Usage Model
6.1. By Single Department
6.2. By Multiple Departments
6.3. By Multiple Sites
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Novarad Corporation (U.S.)
2. Koninklijke Philips N.V. (Netherlands)
3. INFINITT Healthcare Co. Ltd. (South Korea)
4. Siemens Healthineers AG (Germany)
5. Hyland Software Inc. (U.S.)
6. Agfa-Gevaert Group (U.S.)
7. GE Company (U.S.)
8. Mach7 Technologies (U.S.)
9. FUJIFILM Holdings Corporation (Japan)
10. BridgeHead Software Ltd. (U.K.)
11. IBM Corporation (U.S.)
12. Sectra AB (Sweden)
13. ASPYRA
14. LLC (U.S.)
15. and Change Healthcare Inc. (U.S.)
16.
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By